title: [Clinical significance of serum acid soluble glycoproteins (ASP) and immunosuppressive acidic protein (IAP) in inflammatory diseases and liver diseases].
abstract: In order to study the clinical significance of ASP and IAP, we have measured serum concentration of ASP and IAP in 259 patients with inflammatory diseases, non-inflammatory diseases, autoimmune diseases and liver diseases. Significantly higher correlation (coefficient of correlation = 0.922) was found between ASP and IAP. There were good correlation between ASP, IAP levels and erythrocyte sedimentation rate (ESR), C-reactive protein (CRP). Coefficient of correlation were 0.705 and 0.673 between ESR and ASP, IAP; 0.621 and 0.623 between CRP and ASP,IAP, respectively. There were food correlations between ASP levels and thrombo test (TT) and hepaplastin test (HPT). The positive rate and mean concentration of ASP, IAP in patients with inflammatory diseases were significantly higher than noninflammatory diseases. It is suggested that serum ASP, IAP could be one of the useful indicator for evaluating the clinical course of patients with inflammatory diseases. Serum concentration of ASP, IAP in patients with chronic liver diseases were lower than normal subjects, especially serum levels in patients with decompensated liver cirrhosis and chronic hepatitis (active) were significantly lower than normal subjects. In patients with hepatoma with cirrhosis, serum levels of ASP, IAP were significantly lower than the hepatoma patients without cirrhosis. The determination of ASP, IAP in liver diseases seems to be useful for evaluating the severity of diseases, the effects of therapy and the forecast of prognosis.
authors.forename: K
authors.initials: K
authors.lastname: Shibasaki
authors.forename: K
authors.initials: K
authors.lastname: Soga
authors.forename: M
authors.initials: M
authors.lastname: Toshima
authors.forename: K
authors.initials: K
authors.lastname: Aikawa
authors.forename: T
authors.initials: T
authors.lastname: Itoh
authors.forename: Y
authors.initials: Y
authors.lastname: Takahashi
authors.forename: M
authors.initials: M
authors.lastname: Tsuchimochi
authors.forename: I
authors.initials: I
authors.lastname: Mataga
authors.forename: K
authors.initials: K
authors.lastname: Tsuchikawa
authors.forename: J
authors.initials: J
authors.lastname: Kato
mesh_terms: D001327:Autoimmune Diseases / Q000097:blood; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D007249:Inflammation / Q000097:blood* / Q000276:immunology; D008107:Liver Diseases / Q000097:blood* / Q000276:immunology; D009363:Neoplasm Proteins / Q000097:blood*
chemical_list: D006023:Glycoproteins; D009363:Neoplasm Proteins; C030193:immunosuppressive acidic protein